Isabela C Jeremias
Overview
Explore the profile of Isabela C Jeremias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goncalves C, Rezin G, Ferreira G, Jeremias I, Cardoso M, Carvalho-Silva M, et al.
Acta Neuropsychiatr
. 2016 Mar;
24(3):147-54.
PMID: 26953007
Objective: Considering that mitochondria may be drug targets and some characteristics of drug-mitochondria interactions may still be misjudged because of the difficulty in foreseeing and understanding all possible implications of...
2.
Agostinho F, Reus G, Stringari R, Ribeiro K, Ferreira G, Jeremias I, et al.
Acta Neuropsychiatr
. 2014 Nov;
23(6):282-91.
PMID: 25380039
No abstract available.
3.
Barichello T, Simoes L, Generoso J, Carradore M, Moreira A, Panatto A, et al.
Acta Neuropsychiatr
. 2014 Oct;
25(2):95-100.
PMID: 25287310
Background: Bacterial meningitis is an infection of the central nervous system characterised by strong inflammatory response. The brain is highly dependent on ATP, and the cell energy is obtained through...
4.
Ferreira G, Cardoso M, Jeremias I, Goncalves C, Freitas K, Antonini R, et al.
Braz J Psychiatry
. 2014 Mar;
36(3):220-6.
PMID: 24676049
Objective: Several studies support the hypothesis that metabolism impairment is involved in the pathophysiology of depression and that some antidepressants act by modulating brain energy metabolism. Thus, we evaluated the...
5.
Rezin G, Furlanetto C, Scaini G, Valvassori S, Goncalves C, Ferreira G, et al.
Mol Neurobiol
. 2013 Oct;
49(2):877-92.
PMID: 24126971
Fenproporex (Fen) is converted in vivo into amphetamine, which is used to induce mania-like behaviors in animals. In the present study, we intend to present a new animal model of...
6.
Ferreira G, Scaini G, Jeremias I, Carvalho-Silva M, Goncalves C, Pereira T, et al.
Mol Neurobiol
. 2013 Oct;
49(2):734-40.
PMID: 24091827
Tyrosinemia type II, which is also known as Richner-Hanhart syndrome, is an inborn error of metabolism that is due to a block in the transamination reaction that converts tyrosine to...
7.
Ferreira G, Jeremias I, Scaini G, Carvalho-Silva M, Gomes L, Furlanetto C, et al.
Neurochem Res
. 2013 May;
38(8):1742-6.
PMID: 23690230
Most inborn errors of tyrosine catabolism produce hypertyrosinemia. Neurological manifestations are variable and some patients are developmentally normal, while others show different degrees of developmental retardation. Considering that current data...
8.
Goncalves C, Rezin G, Ferreira G, Jeremias I, Cardoso M, Valvassori S, et al.
Mol Cell Biochem
. 2013 May;
380(1-2):171-6.
PMID: 23636618
Obesity is a chronic and multifactorial disease, whose prevalence is increasing in many countries. Pharmaceutical strategies for the treatment of obesity include drugs that regulate food intake, thermogenesis, fat absorption,...
9.
Scaini G, Mello-Santos L, Furlanetto C, Jeremias I, Mina F, Schuck P, et al.
Mol Neurobiol
. 2013 Apr;
48(3):581-9.
PMID: 23559405
Maple syrup urine disease (MSUD) is a neurometabolic disorder caused by deficiency of the activity of the mitochondrial enzyme complex branched-chain α-keto acid dehydrogenase leading to accumulation of the branched-chain...
10.
Reus G, Scaini G, Furlanetto C, Morais M, Jeremias I, Mello-Santos L, et al.
Neurotox Res
. 2013 Feb;
24(2):251-7.
PMID: 23423652
Studies have shown a relationship between energy metabolism and methylphenidate (MPH); however, there are no studies evaluating the effects of MPH in Krebs cycle. So, we investigated if MPH treatment...